Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
Nicholas J. Viney(Ionis Pharmaceuticals (United States)), Julian C. van Capelleveen(Academic Medical Center), Richard S. Geary(Ionis Pharmaceuticals (United States)), Shuting Xia(Ionis Pharmaceuticals (United States)), Joseph A. Tami(Ionis Pharmaceuticals (United States)), Rosie Z. Yu(Ionis Pharmaceuticals (United States)), Santica M. Marcovina(University of Washington), Steven G. Hughes(Ionis Pharmaceuticals (United States)), Mark J. Graham(Ionis Pharmaceuticals (United States)), Rosanne M. Crooke(Ionis Pharmaceuticals (United States)), Stanley T. Crooke(Ionis Pharmaceuticals (United States)), Joseph L. Witztum(University of California, San Diego), Erik S.G. Stroes(Academic Medical Center), Sotirios Tsimikas(Ionis Pharmaceuticals (United States))
Cited by 743
Abstract
Related Papers
No related papers found
Powered by citation graph analysis